Testing the Impact of the MOHR Follow-up Support
Testing the Impact of the My Own Health Report Intervention With 3 Distinct Options for Structured Follow-up as Compared to a Control Condition
Aperçu de l'étude
Statut
Les conditions
Description détaillée
In previous pilot studies was found that patients in clinics randomized to the MOHR intervention vs. control significantly improved physical activity (p < 0.001) and diet risk behaviors (p < 0.001), as well as other risk factors. However, two gaps were identified. First, clinic partners voiced a need for a more flexible menu of delivery options to feasibly adopt and sustain the intervention. Second, to achieve sustained behavior change, particularly for those with unmet social needs, clinics need to provide structured follow-up. Structured follow-up bundles are part of the ERIC strategy of "enhance uptake and adherence (among patients)" and "technical assistance." In other work, additional reminders and resources improved outcomes of goal-setting interventions in general and among those with unmet social needs, so the study team operationalized these to be delivered either electronically (Reminder and Resources (R2) Message) or by a person (R2 Navigation). To fill these two gaps, we engaged with a subset of both UCHealth and rural primary care clinics and patient advisors to co-develop a menu of delivery options for the MOHR intervention and also a menu of options for the R2 Message and R2 Navigation strategy bundles.
In a randomized comparative effectiveness-implementation trial the study team will enroll 1,000 adult patients with two or more cancer risks (including both insufficient physical activity and fruit/vegetable intake). The study team will evaluate the outcomes of R2 Message and R2 Navigation alone or in combination. Key outcomes include: 1) improvement in behavioral risk factors, 2) representative engagement with R2 Message and R2 Navigation, and 3) improvement in practice value outcomes, including patient experience ratings.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Principal Investigator
- Numéro de téléphone: (303) 724-2268
- E-mail: amy.huebschmann@cuanschutz.edu
Lieux d'étude
-
-
Colorado
-
Aurora, Colorado, États-Unis, 80045
- Recrutement
- University Of Colorado Hospital
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Chercheur principal:
- Amy Huebschmann
-
Denver, Colorado, États-Unis, 80206
- Recrutement
- UCHealth Cherry Creek Medical Center
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Chercheur principal:
- Amy Huebschmann
-
Denver, Colorado, États-Unis, 80045
- Recrutement
- UCHealth Women's Integrated Services in Health (WISH)
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Denver, Colorado, États-Unis, 80230
- Recrutement
- UCHealth Internal Medical Clinic - Lowry
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Chercheur principal:
- Amy Huebschmann
-
Lone Tree, Colorado, États-Unis, 80124
- Recrutement
- UCHealth Lone Tree Medical Center
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Chercheur principal:
- Amy Huebschmann
-
Westminster, Colorado, États-Unis, 80021
- Recrutement
- UCHealth Family Medicine - Westminster
-
Contact:
- Rebekah Gomes
- Numéro de téléphone: 303-724-3115
- E-mail: rebekah.gomes@cuanschutz.edu
-
Chercheur principal:
- Amy Huebschmann
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Adults, aged 18 years and older.
- Completion of the MOHR health risk assessment and goal-setting tool
- Score in the "at-risk" range on both of the following cancer risk assessments: 1) Physical activity risk: less than 150 minutes per week of moderate to vigorous physical activity; Diet risk: Less than 5 servings daily of combined fruit/vegetables
- Patient at one of the participating clinics
Exclusion Criteria:
- Incomplete or no MOHR assessment
- Language preference/proficiency other than English or Spanish
- Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation. Examples include - Indices of advanced illness and frailty, such as dementia (ICD-10 codes F01.50, F01.51, F02.80, F02.81, F03.90, F03.91, F10.27, F10.97, G31.09, G31.83 or dementia medication of Donepezil • Galantamine • Rivastigmine, Memantine, or Donepezil-memantine)).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Control Arm
Standardized version of usual care
|
Regular (standard) care provided by healthcare provider team
|
|
Expérimental: R2 Message Only
Reminder and Resources Messages sent to patient
|
Regular (standard) care provided by healthcare provider team
Patients will be provided reminders and resources using messages sent to patients.
|
|
Expérimental: R2 Navigation only
Reminder and Resources provided to patient via health navigator
|
Regular (standard) care provided by healthcare provider team
Patients will be provided reminders and resources using health navigators calling the patients.
|
|
Expérimental: R2 Message + R2 Navigation
Both reminder and resources messages and navigation provided to the patient
|
Regular (standard) care provided by healthcare provider team
Patients will be provided reminders and resources using messages sent to patients.
Patients will be provided reminders and resources using health navigators calling the patients.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of MOHR risk factors
Délai: From enrollment to the follow-up survey timepoint at 2 months.
|
Primary effectiveness outcome measured on scale from -6 to +6 as change of the number of risk factors improved.
MOHR questions are organized into 6 risk areas: 1) intake of fruits and vegetables; 2) high sugar beverages; 3) fast food; 4) physical activity; 5) stress; and 6) sleep.
Each risk factor is evaluated as low risk, medium risk, or high risk.
Level of improvement in risk factors outcome will be a count score from -6 to 6 (any improvement or decrement in level of risk in each factor will count as 1 or -1).
|
From enrollment to the follow-up survey timepoint at 2 months.
|
|
REACH - specifically representative engagement
Délai: From enrollment to the follow-up survey timepoint at 6 months.
|
Primary implementation outcome.
Representative engagement: Engagement during the follow-up period involves interactions over time of the participant with either or both a navigator or text messages .
Engagement will be assessed percent of navigator calls completed (maximum of 12 over 6 months) and percent of text messages successfully sent (maximum of 60 over 6 months).
To assess whether engagement is representative our primary assessments will be if there is differential engagement across conditions (e.g., an interaction effect) based on 1) number of baseline social needs, 2) Latine vs. non Latine ethnicity or 3) digital literacy.
|
From enrollment to the follow-up survey timepoint at 6 months.
|
|
Patient experience
Délai: From enrollment to the follow up survey time point at 6 months.
|
Primary practice value outcome measured by change in mean score on Patient Assessment of Quality-of-Care subscales of goal setting/tailoring and follow-up/coordination (PACIC).
Scale ranges from almost never (indicating the worst patient experience) to almost always (indicating the best patient experience).
|
From enrollment to the follow up survey time point at 6 months.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 25-0224.cc
- 1R01CA282292-01A1 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .